Case Name: Bausch Health Ireland Ltd. v. Mylan Labs. Ltd., No. 21-10403 (SRC) (JSA), 2022 WL 683084 (D.N.J. Mar. 8, 2022) (Chesler, J.) Drug Product and Patent(s)-in ...

Mylan appealed from a Patent Trial and Appeal Board (Board) discretionary denial of institution of an inter partes review (IPR) proceeding. The Board declined to institute Mylan’s IPR under NHK-Fintiv ...

Mylan Laboratories said on Monday it agreed to acquire troubled drugmaker King Pharmaceuticals Inc. for about $4 billion, adding patent-protected brand drugs to Mylan’s generic-drug offerings.

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

TEL AVIV (MarketWatch) -- Mylan Laboratories Inc., the Pittsburgh pharmaceutical producer, said it definitively agreed to pay 4.9 billion euros, or about $6.7 billion, for the generic-drug operations ...

A recently issued US Food and Drug Administration (FDA) warning letter escalated previously observed issues around quality control at Mylan Pharmaceuticals’ manufacturing facility in Morgantown, WV, ...

Please provide your email address to receive an email when new articles are posted on . Mylan Pharmaceuticals has issued a voluntary recall of one batch of its 100 units/mL insulin glargine injection ...

Billionaire investor Carl Icahn has dropped his $5.39 billion offer to buy Mylan Laboratories Inc. and tendered his shares after regulators opened an investigation of a Mylan pain patch that was ...

Celgene sued over proposed Mylan generic of cancer drug New Jersey dismissed case because no Mylan connection to state Court says venue proper where Mylan filed application (Reuters) - Mylan ...

Following the 13 nonconformities that were revealed during a US Food and Drug Administration (FDA) inspection of a Mylan Pharmaceuticals manufacturing site, Focus obtained a copy of the company’s ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. and Forest Laboratories Inc.'s Forest Laboratories Holdings Ltd. said late Wednesday they have entered into an agreement for the ...

PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...